Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Resveratrol-Like Compound Offers Potential Natural Protection Against Radiation

By LabMedica International staff writers
Posted on 16 May 2011
Amid ongoing worries about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a compound similar to the antioxidant resveratrol could protect against radiation sickness. More...


The report's findings were published in April 14, 2011, in the journal ACS Medicinal Chemistry Letters. Dr. Michael Epperly, Dr. Kazunori Koide, and colleagues from the University of Pittsburgh (PA, USA) explained in their article that radiation exposure, either from accidents or from radiation therapy, can make people ill; higher doses could even cause death.

The US Food and Drug Administration (FDA) are currently assessing a drug for its ability to protect against radiation sickness, but it is difficult to make in large amounts, and the drug has side effects that prevent its use for cancer patients. To overcome these problems, the researchers evaluated whether resveratrol could protect against radiation injuries.

The investigators found that resveratrol protected cells in flasks but did not protect mice from radiation damage. However, the similar natural product called acetyl resveratrol did protect the irradiated mice. It also can be generated easily in large quantities and given orally. The authors cautioned, however, that it has not yet been determined whether acetyl resveratrol is effective when orally administered.

Related Links:

University of Pittsburgh




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.